945922-04-3Relevant articles and documents
SUBSTITUTED BENZIMIDAZOLONES AS ANTI-CANCER AGENTS
-
Paragraph 00275, (2020/06/10)
The present invention relates to compounds of Formula I that function as inhibitors of BCL6 (B-cell lymphoma 6) activity: Formula (I) wherein X, R1, R2, and R3 are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which BCL6activity is implicated.
SUBSTITUTED QUINOLONES III
-
Page/Page column 11, (2009/07/25)
The invention relates to substituted quinolones and to methods for their preparation as well as to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, particularly against cytomegaloviruses.